{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:39:43Z","timestamp":1772213983403,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","award":["4-G5ZN0T7"],"award-info":[{"award-number":["4-G5ZN0T7"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n Introduction<\/jats:title>\n Sarcoidosis is a rare systemic inflammatory granulomatous disease of unknown cause. It can manifest in any organ. The incidence of sarcoidosis varies across countries, and by ethnicity and gender. Delays in the diagnosis of sarcoidosis can lead to extension of the disease and organ impairment. Diagnosis delay is attributed in part to the lack of a single diagnostic test or unified commonly used diagnostic criteria, and to the diversity of disease manifestations and symptom load. There is a paucity of evidence examining the determinants of diagnostic delay in sarcoidosis and the experiences of people with sarcoidosis related to delayed diagnosis. We aim to systematically review available evidence about diagnostic delay in sarcoidosis to elucidate the factors associated with diagnostic delay for this disease in different contexts and settings, and the consequences for people with sarcoidosis.<\/jats:p>\n <\/jats:sec>\n \n Methods and analysis<\/jats:title>\n A systematic search of the literature will be conducted using PubMed\/Medline, Scopus, and ProQuest databases, and sources of grey literature, up to 25th of May 2022, with no limitations on publication date. We will include all study types (qualitative, quantitative, and mixed methods) except review articles, examining diagnostic delay, incorrect diagnosis, missed diagnosis or slow diagnosis of all types of sarcoidosis across all age groups. We will also examine evidence of patients\u2019 experiences associated with diagnostic delay. Only studies in English, German and Indonesian will be included. The outcomes we examine will be diagnostic delay time, patients\u2019 experiences, and factors associated with diagnostic delay in sarcoidosis. Two people will independently screen the titles and abstracts of search results, and then the remaining full-text documents against the inclusion criteria. Disagreements will be resolved with a third reviewer until consensus is reached. Selected studies will be appraised using the Mixed Methods Appraisal Tool (MMAT). A meta-analysis and subgroup analyses of quantitative data will be conducted. Meta-aggregation methods will be used to analyse qualitative data. If there is insufficient data for these analyses, a narrative synthesis will be conducted.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n This review will provide systematic and integrated evidence on the diagnostic delay, associated factors, and experiences of diagnosis delay among people with all types of sarcoidosis. This knowledge may shed light on ways to improve diagnosis delays in diagnosis across different subpopulations, and with different disease presentations.<\/jats:p>\n <\/jats:sec>\n \n Ethics and dissemination<\/jats:title>\n Ethical approval will not be required as no human recruitment or participation will be involved. Findings of the study will be disseminated through publications in peer-reviewed journals, conferences, and symposia.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n PROSPERO Registration number:\n CRD42022307236<\/jats:ext-link>\n . URL of the PROSPERO registration:\n https:\/\/www.crd.york.ac.uk\/PROSPEROFILES\/307236_PROTOCOL_20220127.pdf<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0269762","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T13:31:49Z","timestamp":1677072709000},"page":"e0269762","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic delay of sarcoidosis: Protocol for an integrated systematic review"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-5299","authenticated-orcid":true,"given":"Tergel","family":"Namsrai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Desborough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-9363","authenticated-orcid":true,"given":"Matthew","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-0707","authenticated-orcid":true,"given":"Anne","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"issue":"6","key":"pone.0269762.ref001","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"EV Arkema","year":"2016","journal-title":"European Respiratory Journal"},{"key":"pone.0269762.ref002","doi-asserted-by":"crossref","first-page":"106548","DOI":"10.1016\/j.rmed.2021.106548","article-title":"Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up","volume":"187","author":"MG Sikj\u00e6r","year":"2021","journal-title":"Respiratory Medicine"},{"issue":"2","key":"pone.0269762.ref003","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"T Morimoto","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"1","key":"pone.0269762.ref004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12931-018-0871-3","article-title":"Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study","volume":"19","author":"H-Y Yoon","year":"2018","journal-title":"Respiratory Research"},{"key":"pone.0269762.ref005","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.rmed.2018.03.028","article-title":"Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003\u20132015: A nationwide population-based study","volume":"144","author":"JE Park","year":"2018","journal-title":"Respiratory Medicine"},{"issue":"8","key":"pone.0269762.ref006","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis Based on Health Care Use","volume":"13","author":"RP Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"pone.0269762.ref007","doi-asserted-by":"crossref","first-page":"1900444","DOI":"10.1183\/13993003.00444-2019","article-title":"Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study","volume":"54","author":"LM Fidler","year":"2019","journal-title":"European Respiratory Journal"},{"key":"pone.0269762.ref008","first-page":"1","article-title":"Sarcoidosis: epidemiology, characteristics, and outcomes over 10 years\u2014a single-center study in Pakistan","author":"MJ Akram","year":"2021","journal-title":"Expert Review of Respiratory Medicine"},{"key":"pone.0269762.ref009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2021.05.011","article-title":"Epidemiology of sarcoidosis in northern Spain, 1999\u20132019: A population-based study","volume":"91","author":"R Fern\u00e1ndez-Ram\u00f3n","year":"2021","journal-title":"European Journal of Internal Medicine"},{"issue":"1","key":"pone.0269762.ref010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00408-016-9952-6","article-title":"Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976\u20132013","volume":"195","author":"P Ungprasert","year":"2017","journal-title":"Lung"},{"issue":"3","key":"pone.0269762.ref011","first-page":"380","article-title":"Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences","volume":"34","author":"P Brito-Zer\u00f3n","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"pone.0269762.ref012","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"MA Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"pone.0269762.ref013","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MCP.0b013e32832d0403","article-title":"Fatigue in sarcoidosis: a systematic review.","volume":"15","author":"WP de Kleijn","year":"2009","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"4","key":"pone.0269762.ref014","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000092670","article-title":"Relationship between Symptoms and Quality of Life in a Sarcoidosis Population","volume":"74","author":"HJ Michielsen","year":"2007","journal-title":"Respiration"},{"issue":"14","key":"pone.0269762.ref015","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0b013e3181bacf05","article-title":"Intraepidermal nerve fiber density and its application in sarcoidosis","volume":"73","author":"M Bakkers","year":"2009","journal-title":"Neurology"},{"key":"pone.0269762.ref016","volume-title":"What we\u2019re doing about rare diseases 2022","author":"Department of Health and Aged Care"},{"key":"pone.0269762.ref017","first-page":"169","article-title":"Clinical features and outcomes of asymptomatic pulmonary sarcoidosis. A comparative cohort study","author":"A Iriarte","year":"2020","journal-title":"Respiratory Medicine"},{"issue":"4","key":"pone.0269762.ref018","first-page":"735","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"U Costabel","year":"1999","journal-title":"European Respiratory Journal"},{"key":"pone.0269762.ref019","doi-asserted-by":"crossref","first-page":"105846","DOI":"10.1016\/j.rmed.2019.105846","article-title":"Sarcoidosis diagnosis and treatment in Sweden: A register-based assessment of variations by region and calendar period","volume":"161","author":"M Rossides","year":"2020","journal-title":"Respiratory Medicine"},{"issue":"6","key":"pone.0269762.ref020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/NRL.0b013e3181b287df","article-title":"Neurosarcoidosis Mimicry of Multiple Sclerosis: Clinical, Laboratory, and Imaging Characteristics","volume":"16","author":"TF Scott","year":"2010","journal-title":"The Neurologist"},{"issue":"2","key":"pone.0269762.ref021","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"MA Judson","year":"2003","journal-title":"Chest"},{"issue":"1","key":"pone.0269762.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Systematic Reviews"},{"key":"pone.0269762.ref023","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.2","author":"TJ Higgins JPT","year":"2021"},{"issue":"1","key":"pone.0269762.ref024","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"AM Methley","year":"2014","journal-title":"BMC Health Services Research"},{"key":"pone.0269762.ref025","volume-title":"Covidence systematic review software Melbourne","author":"Veritas Health Innovation"},{"key":"pone.0269762.ref026","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"QN Hong","year":"2018","journal-title":"Education for Information"},{"issue":"15","key":"pone.0269762.ref027","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting","volume":"283","author":"DF Stroup","year":"2000","journal-title":"JAMA"},{"key":"pone.0269762.ref028","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"JAC Sterne","year":"2011","journal-title":"BMJ"},{"key":"pone.0269762.ref029","volume-title":"Systematic Reviews.","author":"Centre for Reviews and Dissemination","year":"2009"},{"issue":"4","key":"pone.0269762.ref030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"H Balshem","year":"2011","journal-title":"J Clin Epidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T13:32:12Z","timestamp":1677072732000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269762"}},"subtitle":[],"editor":[{"given":"Muhammad Shahzad","family":"Aslam","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0269762","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.05.30.22275771","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}